462 related articles for article (PubMed ID: 19785373)
1. [The importance of autologous transplantation in multiple myeloma].
Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
[TBL] [Abstract][Full Text] [Related]
2. [High-dosage chemotherapy with support of autologous haematopoietic cells in the treatment of multiple myeloma--review of contemporary possibilities].
Rácil Z; Adam Z; Hájek R; Tomíska M; Krejcí M; Krivanová A; Höklová J; Doubek M; Mayer J; Vorlícek J
Vnitr Lek; 2001 Feb; 47(2):92-8. PubMed ID: 15635853
[TBL] [Abstract][Full Text] [Related]
3. Current status of autologous hematopoietic stem cell transplantation in myeloma.
Mehta J; Singhal S
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S28-S34. PubMed ID: 18724294
[TBL] [Abstract][Full Text] [Related]
4. [Stem cell transplantation in multiple myeloma].
Fukuda S; Sunami K; Sezaki T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1407-14. PubMed ID: 10500527
[TBL] [Abstract][Full Text] [Related]
5. Autologous stem-cell transplantation in multiple myeloma.
Gahrton G
Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254
[TBL] [Abstract][Full Text] [Related]
6. The role of autologous stem cell transplantation in the management of multiple myeloma.
Fermand JP; Brechignac S
Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
Mehta J; Singhal S
Bone Marrow Transplant; 2007 Dec; 40(12):1101-14. PubMed ID: 17680020
[TBL] [Abstract][Full Text] [Related]
8. [Autologous transplantation of peripheral stem cells in treatment of recurrent multiple myeloma].
Krejcí M; Adam Z; Mayer J; Hájek R; Vorlícek J
Vnitr Lek; 1998 Dec; 44(12):698-701. PubMed ID: 10422512
[TBL] [Abstract][Full Text] [Related]
9. Role of autologous stem-cell transplantation in multiple myeloma.
Attal M; Harousseau JL
Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
[TBL] [Abstract][Full Text] [Related]
10. High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future.
Björkstrand B; Gahrton G
Semin Hematol; 2007 Oct; 44(4):227-33. PubMed ID: 17961721
[TBL] [Abstract][Full Text] [Related]
11. [Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].
Krejcí M; Doubek M; Adam Z; Hájek R; Vorlícek J; Mayer J
Vnitr Lek; 1997 Nov; 43(11):756-8. PubMed ID: 9650509
[TBL] [Abstract][Full Text] [Related]
12. The role of autologous blood stem cells in support of high-dose therapy for multiple myeloma.
Fermand JP; Chevret S; Levy Y; Miclea JM; Tsapis A; Gerota J; Benbunan M; Brouet JC
Hematol Oncol Clin North Am; 1992 Apr; 6(2):451-62. PubMed ID: 1349886
[TBL] [Abstract][Full Text] [Related]
13. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N
J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705
[TBL] [Abstract][Full Text] [Related]
14. Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.
Lenhoff S; Hjorth M; Turesson I; Westin J; Gimsing P; Wislöff F; Ahlberg L; Carlson K; Christiansen I; Dahl IM; Forsberg K; Brinch L; Hammerström J; Johnsen HE; Knudsen LM; Linder O; Mellqvist UH; Nesthus I; Nielsen JL;
Haematologica; 2006 Sep; 91(9):1228-33. PubMed ID: 16956822
[TBL] [Abstract][Full Text] [Related]
15. Autologous stem cell transplantation in the elderly including pre- and post-treatment options.
Kumar SK; Hayman SR; Kyle RA
Bone Marrow Transplant; 2007 Dec; 40(12):1115-21. PubMed ID: 17680019
[TBL] [Abstract][Full Text] [Related]
16. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
17. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
Klepin HD; Hurd DD
Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
[TBL] [Abstract][Full Text] [Related]
18. High-dose therapy in multiple myeloma and primary amyloidosis: an overview.
Kyle RA
Semin Oncol; 1999 Feb; 26(1):74-83. PubMed ID: 10073564
[TBL] [Abstract][Full Text] [Related]
19. Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
Harousseau JL; Avet-Loiseau H; Attal M; Charbonnel C; Garban F; Hulin C; Michallet M; Facon T; Garderet L; Marit G; Ketterer N; Lamy T; Voillat L; Guilhot F; Doyen C; Mathiot C; Moreau P
J Clin Oncol; 2009 Dec; 27(34):5720-6. PubMed ID: 19826130
[TBL] [Abstract][Full Text] [Related]
20. Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma.
Reichardt VL; Okada CY; Stockerl-Goldstein KE; Bogen B; Levy R
Biol Blood Marrow Transplant; 1997 Aug; 3(3):157-63. PubMed ID: 9310193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
